Identifying Selective Inhibitors for Staphylococcus aureus Enzymes
Author Information
Author(s): Matthew Bogyo, Tulsi Upadhyay, Emily Woods, Stephen Ahator, Kjersti Julin, Franco Faucher, Marijn Hollander, Nichole Pedowitz, Daniel Abegg, Isabella Hammond, Ifeanyichukwu Eke, Sijie Wang, Shiyu Chen, John Bennett, Jeyun Jo, Christian Lentz, Alex Adibekian, Matthias Fellner
Primary Institution: Stanford University
Hypothesis
Can a high-throughput screening approach identify selective inhibitors for Staphylococcus aureus serine hydrolases?
Conclusion
The study successfully identified selective inhibitors for three serine hydrolases in Staphylococcus aureus, which could be potential therapeutic targets.
Supporting Evidence
- Selective inhibitors of FphH impaired bacterial growth and biofilm formation.
- High-throughput screening identified 371 active hits across three enzymes.
- X-ray crystallography validated the binding mode of several inhibitors.
Takeaway
Researchers found special medicines that can stop bad bacteria from growing and forming protective layers, which helps in treating infections.
Methodology
The study used a high-throughput screening of a library of 1,600 covalent electrophiles against three serine hydrolases in Staphylococcus aureus.
Limitations
The study may not account for all potential interactions and effects in a living organism.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website